The global osteoarthritis therapeutics market size is estimated to reach USD 13.57 billion by 2030 and is projected to grow at a CAGR of 6.82% from 2024 to 2030. The osteoarthritis therapeutics market is on the rise, driven by an increase in OA cases, especially among the aging population. In the U.S. alone, there are over 32.5 million OA patients, highlighting the demand for effective treatments. Ongoing research and development efforts are focused on creating new therapies, with a particular emphasis on understanding the disease and developing solutions to address its challenges. ![Global Osteoarthritis Therapeutics Market]( "Global Osteoarthritis Therapeutics Market")
Managing OA proves difficult owing to its dense tissue structure, but the introduction of novel drugs such as intra-articular drug administration has accelerated the development of targeted drug delivery. Researchers are actively exploring disease-modifying drugs and bioadaptive carriers to enhance the development of innovative osteoarthritis treatments. Market players are taking initiatives to contribute to market expansion, as seen with OrthoTrophix, Inc. presenting clinical data and a registration plan for TPX-100 for knee osteoarthritis at BIO 2022.
In addition, significant efforts are being made by key pharmaceutical companies and research institutes in realm of research and development, especially for disease-modifying osteoarthritis drugs. For instance, BioSenic's Phase 3 data presentation at the 2024 OARSI World Congress showcased the efficacy of JTA-004 in treating severe inflammatory knee osteoarthritis. The post hoc analysis concluded that JTA-004 is both safe and effective, offering targeted pain management for this specific subtype of condition. These advancements in targeted drug delivery and disease-modifying drugs, as demonstrated by presentations and positive trial results, are contributing to the expansion of the market for novel osteoarthritis treatments.
Moreover, the market for OA is experiencing significant growth owing to the introduction of personalized medications such as Bisphosphonates (anti-resorptive drugs) and Synvisc-ONE injection. In addition, pharmaceutical companies and research institutions are actively engaged in developing personalized treatments and cell-based therapies for OA. In December 2023, researchers at Columbia University made a breakthrough discovery of stem cells in adult mice capable of maintaining healthy cartilage in joints, with their decline contributing to OA development due to aging and injury.
Investing in this sector offers companies the opportunity to capitalize on evolving demands, thus gaining a competitive advantage. By leading innovative medication development, companies establish themselves as frontrunners, solidifying their position in the market. The advent of personalized OA medications and advancements in cell-based therapies are key drivers of market expansion, empowering companies to emerge as leaders in the field.
This product will be delivered within 1-3 business days.
Managing OA proves difficult owing to its dense tissue structure, but the introduction of novel drugs such as intra-articular drug administration has accelerated the development of targeted drug delivery. Researchers are actively exploring disease-modifying drugs and bioadaptive carriers to enhance the development of innovative osteoarthritis treatments. Market players are taking initiatives to contribute to market expansion, as seen with OrthoTrophix, Inc. presenting clinical data and a registration plan for TPX-100 for knee osteoarthritis at BIO 2022.
In addition, significant efforts are being made by key pharmaceutical companies and research institutes in realm of research and development, especially for disease-modifying osteoarthritis drugs. For instance, BioSenic's Phase 3 data presentation at the 2024 OARSI World Congress showcased the efficacy of JTA-004 in treating severe inflammatory knee osteoarthritis. The post hoc analysis concluded that JTA-004 is both safe and effective, offering targeted pain management for this specific subtype of condition. These advancements in targeted drug delivery and disease-modifying drugs, as demonstrated by presentations and positive trial results, are contributing to the expansion of the market for novel osteoarthritis treatments.
Moreover, the market for OA is experiencing significant growth owing to the introduction of personalized medications such as Bisphosphonates (anti-resorptive drugs) and Synvisc-ONE injection. In addition, pharmaceutical companies and research institutions are actively engaged in developing personalized treatments and cell-based therapies for OA. In December 2023, researchers at Columbia University made a breakthrough discovery of stem cells in adult mice capable of maintaining healthy cartilage in joints, with their decline contributing to OA development due to aging and injury.
Investing in this sector offers companies the opportunity to capitalize on evolving demands, thus gaining a competitive advantage. By leading innovative medication development, companies establish themselves as frontrunners, solidifying their position in the market. The advent of personalized OA medications and advancements in cell-based therapies are key drivers of market expansion, empowering companies to emerge as leaders in the field.
Osteoarthritis Therapeutics Market Report Highlights
- Based on drug type, the viscosupplementation agents segment led the market with the largest revenue share of 36.63% in 2023, osteoarthritis therapeutics market due to their adoption and efficacy in managing OA symptoms
- Based on anatomy, the knee osteoarthritis segment held a market with the largest revenue share of 41.96% in 2023. Knee osteoarthritis is one of the most common forms of chronic articular disease and osteoarthritis worldwide and is characterized by high disability & morbidity rates
- Based on route of administration, the parenteral route segment held the market with the largest revenue share of 39.94% in 2023 and is expected to grow at a CAGR of 7.50% over the forecast period, due to its efficacy for certain therapies, better pharmacokinetics and pharmacodynamics, and ease of administration
- Based on end-use, the hospital pharmacies segment held the market with the largest revenue share of 47.64% in 2023, owing to high hospitalization associated with OA
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Drug Type
1.2.2. Anatomy
1.2.3. Route of Administration
1.2.4. Sales Channel
1.2.5. End Use
1.2.6. Regional scope
1.2.7. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. Internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for Primary Interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for Primary Interviews in Latin America
1.4.5.5. Data for Primary Interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
1.2. Segment Definitions
1.2.1. Drug Type
1.2.2. Anatomy
1.2.3. Route of Administration
1.2.4. Sales Channel
1.2.5. End Use
1.2.6. Regional scope
1.2.7. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. Internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for Primary Interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for Primary Interviews in Latin America
1.4.5.5. Data for Primary Interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Drug type outlook
2.2.2. Anatomy outlook
2.2.3. Route of administration outlook
2.2.4. Sales channel outlook
2.2.5. End-use outlook
2.2.6. Regional outlook
2.3. Competitive Insights
2.2. Segment Outlook
2.2.1. Drug type outlook
2.2.2. Anatomy outlook
2.2.3. Route of administration outlook
2.2.4. Sales channel outlook
2.2.5. End-use outlook
2.2.6. Regional outlook
2.3. Competitive Insights
Chapter 3. Osteoarthritis Therapeutics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. High Prevalence of Osteoarthritis
3.2.1.2. Growing Aging Population
3.2.1.3. Technological Advancements
3.2.2. Market Restraint Analysis
3.2.2.1. Side Effects and adverse reactions
3.2.2.2. High cost of osteoarthritis therapeutics drugs
3.3. Osteoarthritis Therapeutics Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic Landscape
3.3.3. Pricing Analysis
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. High Prevalence of Osteoarthritis
3.2.1.2. Growing Aging Population
3.2.1.3. Technological Advancements
3.2.2. Market Restraint Analysis
3.2.2.1. Side Effects and adverse reactions
3.2.2.2. High cost of osteoarthritis therapeutics drugs
3.3. Osteoarthritis Therapeutics Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic Landscape
3.3.3. Pricing Analysis
Chapter 4. Osteoarthritis Therapeutics Market: Drug Type Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global Osteoarthritis Therapeutics Market by Drug Type Outlook
4.3. Global Osteoarthritis Therapeutics Market Size & Trend Analysis, by Drug Type, 2018 to 2030 (USD Million)
4.4. Viscosupplementation Agents
4.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Nonsteroidal Anti-inflammatory Drugs
4.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.1.1. Naproxen
4.5.1.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.1.2. Aspirin
4.5.1.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.1.3. Diclofenac
4.5.1.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.1.4. Ibuprofen
4.5.1.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.1.5. Celecoxib
4.5.1.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.1.6. Meloxicam
4.5.1.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.1.7. Piroxicam
4.5.1.7.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.1.8. Ketoprofen
4.5.1.8.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.1.9. Other NSAIDs
4.5.1.9.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.2. Analgesics
4.5.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.2.1.1. Duloxetine
4.5.2.1.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.2.1.2. Acetaminophen
4.5.2.1.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.3. Corticosteroids
4.5.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.4. Others
4.5.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.2. Global Osteoarthritis Therapeutics Market by Drug Type Outlook
4.3. Global Osteoarthritis Therapeutics Market Size & Trend Analysis, by Drug Type, 2018 to 2030 (USD Million)
4.4. Viscosupplementation Agents
4.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Nonsteroidal Anti-inflammatory Drugs
4.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.1.1. Naproxen
4.5.1.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.1.2. Aspirin
4.5.1.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.1.3. Diclofenac
4.5.1.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.1.4. Ibuprofen
4.5.1.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.1.5. Celecoxib
4.5.1.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.1.6. Meloxicam
4.5.1.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.1.7. Piroxicam
4.5.1.7.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.1.8. Ketoprofen
4.5.1.8.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.1.9. Other NSAIDs
4.5.1.9.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.2. Analgesics
4.5.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.2.1.1. Duloxetine
4.5.2.1.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.2.1.2. Acetaminophen
4.5.2.1.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.3. Corticosteroids
4.5.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.4. Others
4.5.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Osteoarthritis Therapeutics Market: Anatomy Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global Osteoarthritis Therapeutics Market Movement Analysis
5.3. Global Osteoarthritis Therapeutics Market Size & Trend Analysis, by Anatomy, 2018 to 2030 (USD Million)
5.4. Knee Osteoarthritis
5.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Hip Osteoarthritis
5.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Hand Osteoarthritis
5.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
5.7. Others
5.7.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
5.2. Global Osteoarthritis Therapeutics Market Movement Analysis
5.3. Global Osteoarthritis Therapeutics Market Size & Trend Analysis, by Anatomy, 2018 to 2030 (USD Million)
5.4. Knee Osteoarthritis
5.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Hip Osteoarthritis
5.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Hand Osteoarthritis
5.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
5.7. Others
5.7.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Osteoarthritis Therapeutics Market: Route of Administration Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Global Osteoarthritis Therapeutics Market Movement Analysis
6.3. Global Osteoarthritis Therapeutics Market Size & Trend Analysis, by Route of Administration, 2018 to 2030 (USD Million)
6.4. Parenteral Route
6.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.4.1.1. Hyaluronic Acid Injections
6.4.1.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.4.1.2. Corticosteroid Injections
6.4.1.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.4.1.3. Platelet-rich Plasma (PRP) Injections
6.4.1.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.4.1.4. Placental Tissue Matrix (PTM) Injections
6.4.1.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.4.1.5. Acetylsalicylic Acid (ASA) Injections
6.4.1.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.4.1.6. Others
6.4.1.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Topical Route
6.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.6. Oral Route
6.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.2. Global Osteoarthritis Therapeutics Market Movement Analysis
6.3. Global Osteoarthritis Therapeutics Market Size & Trend Analysis, by Route of Administration, 2018 to 2030 (USD Million)
6.4. Parenteral Route
6.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.4.1.1. Hyaluronic Acid Injections
6.4.1.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.4.1.2. Corticosteroid Injections
6.4.1.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.4.1.3. Platelet-rich Plasma (PRP) Injections
6.4.1.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.4.1.4. Placental Tissue Matrix (PTM) Injections
6.4.1.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.4.1.5. Acetylsalicylic Acid (ASA) Injections
6.4.1.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.4.1.6. Others
6.4.1.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Topical Route
6.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.6. Oral Route
6.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Osteoarthritis Therapeutics Market: Sales Channel Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Global Osteoarthritis Therapeutics Market Movement Analysis
7.3. Global Osteoarthritis Therapeutics Market Size & Trend Analysis, by Sales Channel, 2018 to 2030 (USD Million)
7.4. Prescription Drugs
7.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
7.5. Over-the-Counter Drugs
7.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
7.2. Global Osteoarthritis Therapeutics Market Movement Analysis
7.3. Global Osteoarthritis Therapeutics Market Size & Trend Analysis, by Sales Channel, 2018 to 2030 (USD Million)
7.4. Prescription Drugs
7.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
7.5. Over-the-Counter Drugs
7.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 8. Osteoarthritis Therapeutics Market: End-use Estimates & Trend Analysis
8.1. Segment Dashboard
8.2. Global Osteoarthritis Therapeutics Market Movement Analysis
8.3. Global Osteoarthritis Therapeutics Market Size & Trend Analysis, by End Use 2018 to 2030 (USD Million)
8.4. Hospital Pharmacies
8.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
8.5. Retail Pharmacies
8.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
8.6. Others
8.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
8.2. Global Osteoarthritis Therapeutics Market Movement Analysis
8.3. Global Osteoarthritis Therapeutics Market Size & Trend Analysis, by End Use 2018 to 2030 (USD Million)
8.4. Hospital Pharmacies
8.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
8.5. Retail Pharmacies
8.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
8.6. Others
8.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 9. Osteoarthritis Therapeutics Market: Regional Estimates & Trend Analysis by
9.1. Regional Market Dashboard
9.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
9.3. North America
9.3.1. U.S.
9.3.1.1. Key country dynamics
9.3.1.2. Regulatory framework/ reimbursement structure
9.3.1.3. Competitive scenario
9.3.1.4. U.S. market estimates and forecasts, 2018 to 2030 (USD Million)
9.3.2. Canada
9.3.2.1. Key country dynamics
9.3.2.2. Regulatory framework/ reimbursement structure
9.3.2.3. Competitive scenario
9.3.2.4. Canada market estimates and forecasts, 2018 to 2030 (USD Million)
9.4. Europe
9.4.1. UK
9.4.1.1. Key country dynamics
9.4.1.2. Regulatory framework/ reimbursement structure
9.4.1.3. Competitive scenario
9.4.1.4. UK market estimates and forecasts, 2018 to 2030 (USD Million)
9.4.2. Germany
9.4.2.1. Key country dynamics
9.4.2.2. Regulatory framework/ reimbursement structure
9.4.2.3. Competitive scenario
9.4.2.4. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
9.4.3. France
9.4.3.1. Key country dynamics
9.4.3.2. Regulatory framework/ reimbursement structure
9.4.3.3. Competitive scenario
9.4.3.4. France market estimates and forecasts, 2018 to 2030 (USD Million)
9.4.4. Italy
9.4.4.1. Key country dynamics
9.4.4.2. Regulatory framework/ reimbursement structure
9.4.4.3. Competitive scenario
9.4.4.4. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
9.4.5. Spain
9.4.5.1. Key country dynamics
9.4.5.2. Regulatory framework/ reimbursement structure
9.4.5.3. Competitive scenario
9.4.5.4. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
9.4.6. Norway
9.4.6.1. Key country dynamics
9.4.6.2. Regulatory framework/ reimbursement structure
9.4.6.3. Competitive scenario
9.4.6.4. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
9.4.7. Sweden
9.4.7.1. Key country dynamics
9.4.7.2. Regulatory framework/ reimbursement structure
9.4.7.3. Competitive scenario
9.4.7.4. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
9.4.8. Denmark
9.4.8.1. Key country dynamics
9.4.8.2. Regulatory framework/ reimbursement structure
9.4.8.3. Competitive scenario
9.4.8.4. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
9.5. Asia Pacific
9.5.1. Japan
9.5.1.1. Key country dynamics
9.5.1.2. Regulatory framework/ reimbursement structure
9.5.1.3. Competitive scenario
9.5.1.4. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
9.5.2. China
9.5.2.1. Key country dynamics
9.5.2.2. Regulatory framework/ reimbursement structure
9.5.2.3. Competitive scenario
9.5.2.4. China market estimates and forecasts, 2018 to 2030 (USD Million)
9.5.3. India
9.5.3.1. Key country dynamics
9.5.3.2. Regulatory framework/ reimbursement structure
9.5.3.3. Competitive scenario
9.5.3.4. India market estimates and forecasts, 2018 to 2030 (USD Million)
9.5.4. Australia
9.5.4.1. Key country dynamics
9.5.4.2. Regulatory framework/ reimbursement structure
9.5.4.3. Competitive scenario
9.5.4.4. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
9.5.5. South Korea
9.5.5.1. Key country dynamics
9.5.5.2. Regulatory framework/ reimbursement structure
9.5.5.3. Competitive scenario
9.5.5.4. South Korea market estimates and forecasts, 2018 to 2030 (USD Million)
9.5.6. Thailand
9.5.6.1. Key country dynamics
9.5.6.2. Regulatory framework/ reimbursement structure
9.5.6.3. Competitive scenario
9.5.6.4. Thailand market estimates and forecasts, 2018 to 2030 (USD Million)
9.6. Latin America
9.6.1. Brazil
9.6.1.1. Key country dynamics
9.6.1.2. Regulatory framework/ reimbursement structure
9.6.1.3. Competitive scenario
9.6.1.4. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
9.6.2. Mexico
9.6.2.1. Key country dynamics
9.6.2.2. Regulatory framework/ reimbursement structure
9.6.2.3. Competitive scenario
9.6.2.4. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
9.6.3. Argentina
9.6.3.1. Key country dynamics
9.6.3.2. Regulatory framework/ reimbursement structure
9.6.3.3. Competitive scenario
9.6.3.4. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
9.7. MEA
9.7.1. South Africa
9.7.1.1. Key country dynamics
9.7.1.2. Regulatory framework/ reimbursement structure
9.7.1.3. Competitive scenario
9.7.1.4. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
9.7.2. Saudi Arabia
9.7.2.1. Key country dynamics
9.7.2.2. Regulatory framework/ reimbursement structure
9.7.2.3. Competitive scenario
9.7.2.4. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Million)
9.7.3. UAE
9.7.3.1. Key country dynamics
9.7.3.2. Regulatory framework/ reimbursement structure
9.7.3.3. Competitive scenario
9.7.3.4. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
9.7.4. Kuwait
9.7.4.1. Key country dynamics
9.7.4.2. Regulatory framework/ reimbursement structure
9.7.4.3. Competitive scenario
9.7.4.4. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)
9.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
9.3. North America
9.3.1. U.S.
9.3.1.1. Key country dynamics
9.3.1.2. Regulatory framework/ reimbursement structure
9.3.1.3. Competitive scenario
9.3.1.4. U.S. market estimates and forecasts, 2018 to 2030 (USD Million)
9.3.2. Canada
9.3.2.1. Key country dynamics
9.3.2.2. Regulatory framework/ reimbursement structure
9.3.2.3. Competitive scenario
9.3.2.4. Canada market estimates and forecasts, 2018 to 2030 (USD Million)
9.4. Europe
9.4.1. UK
9.4.1.1. Key country dynamics
9.4.1.2. Regulatory framework/ reimbursement structure
9.4.1.3. Competitive scenario
9.4.1.4. UK market estimates and forecasts, 2018 to 2030 (USD Million)
9.4.2. Germany
9.4.2.1. Key country dynamics
9.4.2.2. Regulatory framework/ reimbursement structure
9.4.2.3. Competitive scenario
9.4.2.4. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
9.4.3. France
9.4.3.1. Key country dynamics
9.4.3.2. Regulatory framework/ reimbursement structure
9.4.3.3. Competitive scenario
9.4.3.4. France market estimates and forecasts, 2018 to 2030 (USD Million)
9.4.4. Italy
9.4.4.1. Key country dynamics
9.4.4.2. Regulatory framework/ reimbursement structure
9.4.4.3. Competitive scenario
9.4.4.4. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
9.4.5. Spain
9.4.5.1. Key country dynamics
9.4.5.2. Regulatory framework/ reimbursement structure
9.4.5.3. Competitive scenario
9.4.5.4. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
9.4.6. Norway
9.4.6.1. Key country dynamics
9.4.6.2. Regulatory framework/ reimbursement structure
9.4.6.3. Competitive scenario
9.4.6.4. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
9.4.7. Sweden
9.4.7.1. Key country dynamics
9.4.7.2. Regulatory framework/ reimbursement structure
9.4.7.3. Competitive scenario
9.4.7.4. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
9.4.8. Denmark
9.4.8.1. Key country dynamics
9.4.8.2. Regulatory framework/ reimbursement structure
9.4.8.3. Competitive scenario
9.4.8.4. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
9.5. Asia Pacific
9.5.1. Japan
9.5.1.1. Key country dynamics
9.5.1.2. Regulatory framework/ reimbursement structure
9.5.1.3. Competitive scenario
9.5.1.4. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
9.5.2. China
9.5.2.1. Key country dynamics
9.5.2.2. Regulatory framework/ reimbursement structure
9.5.2.3. Competitive scenario
9.5.2.4. China market estimates and forecasts, 2018 to 2030 (USD Million)
9.5.3. India
9.5.3.1. Key country dynamics
9.5.3.2. Regulatory framework/ reimbursement structure
9.5.3.3. Competitive scenario
9.5.3.4. India market estimates and forecasts, 2018 to 2030 (USD Million)
9.5.4. Australia
9.5.4.1. Key country dynamics
9.5.4.2. Regulatory framework/ reimbursement structure
9.5.4.3. Competitive scenario
9.5.4.4. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
9.5.5. South Korea
9.5.5.1. Key country dynamics
9.5.5.2. Regulatory framework/ reimbursement structure
9.5.5.3. Competitive scenario
9.5.5.4. South Korea market estimates and forecasts, 2018 to 2030 (USD Million)
9.5.6. Thailand
9.5.6.1. Key country dynamics
9.5.6.2. Regulatory framework/ reimbursement structure
9.5.6.3. Competitive scenario
9.5.6.4. Thailand market estimates and forecasts, 2018 to 2030 (USD Million)
9.6. Latin America
9.6.1. Brazil
9.6.1.1. Key country dynamics
9.6.1.2. Regulatory framework/ reimbursement structure
9.6.1.3. Competitive scenario
9.6.1.4. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
9.6.2. Mexico
9.6.2.1. Key country dynamics
9.6.2.2. Regulatory framework/ reimbursement structure
9.6.2.3. Competitive scenario
9.6.2.4. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
9.6.3. Argentina
9.6.3.1. Key country dynamics
9.6.3.2. Regulatory framework/ reimbursement structure
9.6.3.3. Competitive scenario
9.6.3.4. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
9.7. MEA
9.7.1. South Africa
9.7.1.1. Key country dynamics
9.7.1.2. Regulatory framework/ reimbursement structure
9.7.1.3. Competitive scenario
9.7.1.4. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
9.7.2. Saudi Arabia
9.7.2.1. Key country dynamics
9.7.2.2. Regulatory framework/ reimbursement structure
9.7.2.3. Competitive scenario
9.7.2.4. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Million)
9.7.3. UAE
9.7.3.1. Key country dynamics
9.7.3.2. Regulatory framework/ reimbursement structure
9.7.3.3. Competitive scenario
9.7.3.4. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
9.7.4. Kuwait
9.7.4.1. Key country dynamics
9.7.4.2. Regulatory framework/ reimbursement structure
9.7.4.3. Competitive scenario
9.7.4.4. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 10. Competitive Landscape
10.1. Recent Developments & Impact Analysis, By Key Market Participants
10.2. Company/Competition Categorization
10.3. Vendor Landscape
10.3.1. List of key distributors and channel partners
10.3.2. Key customers
10.3.3. Key company market share analysis, 2023
10.3.4. Sanofi SA
10.3.4.1. Company overview
10.3.4.2. Financial performance
10.3.4.3. Product benchmarking
10.3.4.4. Strategic initiatives
10.3.5. GlaxoSmithKline plc
10.3.5.1. Company overview
10.3.5.2. Financial performance
10.3.5.3. Product benchmarking
10.3.5.4. Strategic initiatives
10.3.6. Pfizer Inc.
10.3.6.1. Company overview
10.3.6.2. Financial performance
10.3.6.3. Product benchmarking
10.3.6.4. Strategic initiatives
10.3.7. Bayer AG
10.3.7.1. Company overview
10.3.7.2. Financial performance
10.3.7.3. Product benchmarking
10.3.7.4. Strategic initiatives
10.3.8. Zimmer Biomet
10.3.8.1. Company overview
10.3.8.2. Financial performance
10.3.8.3. Product benchmarking
10.3.8.4. Strategic initiatives
10.3.9. Novartis AG
10.3.9.1. Company overview
10.3.9.2. Financial performance
10.3.9.3. Product benchmarking
10.3.9.4. Strategic initiatives
10.3.10. Anika Therapeutics
10.3.10.1. Company overview
10.3.10.2. Financial performance
10.3.10.3. Product benchmarking
10.3.10.4. Strategic initiatives
10.3.11. Assertio Therapeutics, Inc.
10.3.11.1. Company overview
10.3.11.2. Financial performance
10.3.11.3. Product benchmarking
10.3.11.4. Strategic initiatives
10.3.12. Bioventus
10.3.12.1. Company overview
10.3.12.2. Financial performance
10.3.12.3. Product benchmarking
10.3.12.4. Strategic initiatives
10.3.13. Ferring Pharmaceuticals Inc.
10.3.13.1. Company overview
10.3.13.2. Financial performance
10.3.13.3. Product benchmarking
10.3.13.4. Strategic initiatives
10.2. Company/Competition Categorization
10.3. Vendor Landscape
10.3.1. List of key distributors and channel partners
10.3.2. Key customers
10.3.3. Key company market share analysis, 2023
10.3.4. Sanofi SA
10.3.4.1. Company overview
10.3.4.2. Financial performance
10.3.4.3. Product benchmarking
10.3.4.4. Strategic initiatives
10.3.5. GlaxoSmithKline plc
10.3.5.1. Company overview
10.3.5.2. Financial performance
10.3.5.3. Product benchmarking
10.3.5.4. Strategic initiatives
10.3.6. Pfizer Inc.
10.3.6.1. Company overview
10.3.6.2. Financial performance
10.3.6.3. Product benchmarking
10.3.6.4. Strategic initiatives
10.3.7. Bayer AG
10.3.7.1. Company overview
10.3.7.2. Financial performance
10.3.7.3. Product benchmarking
10.3.7.4. Strategic initiatives
10.3.8. Zimmer Biomet
10.3.8.1. Company overview
10.3.8.2. Financial performance
10.3.8.3. Product benchmarking
10.3.8.4. Strategic initiatives
10.3.9. Novartis AG
10.3.9.1. Company overview
10.3.9.2. Financial performance
10.3.9.3. Product benchmarking
10.3.9.4. Strategic initiatives
10.3.10. Anika Therapeutics
10.3.10.1. Company overview
10.3.10.2. Financial performance
10.3.10.3. Product benchmarking
10.3.10.4. Strategic initiatives
10.3.11. Assertio Therapeutics, Inc.
10.3.11.1. Company overview
10.3.11.2. Financial performance
10.3.11.3. Product benchmarking
10.3.11.4. Strategic initiatives
10.3.12. Bioventus
10.3.12.1. Company overview
10.3.12.2. Financial performance
10.3.12.3. Product benchmarking
10.3.12.4. Strategic initiatives
10.3.13. Ferring Pharmaceuticals Inc.
10.3.13.1. Company overview
10.3.13.2. Financial performance
10.3.13.3. Product benchmarking
10.3.13.4. Strategic initiatives
List of Tables
Table 1 List of key distributors and channel partners
Table 2 List of key emerging companies/technology disruptors/innovators
Table 3 North America Osteoarthritis Therapeutics Market, by country, 2018 - 2030 (USD Million)
Table 4 North America Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
Table 5 North America Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
Table 6 North America Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 7 North America Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 8 North America Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
Table 9 U.S. Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
Table 10 U.S. Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
Table 11 U.S. Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 12 U.S. Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 13 U.S. Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
Table 14 Canada Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
Table 15 Canada Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
Table 16 Canada Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 17 Canada Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 18 Canada Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
Table 19 Europe Osteoarthritis Therapeutics Market, by country, 2018 - 2030 (USD Million)
Table 20 Europe Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
Table 21 Europe Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
Table 22 Europe Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 23 Europe Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 24 Europe Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
Table 25 Germany Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
Table 26 Germany Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
Table 27 Germany Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 28 Germany Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 29 Germany Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
Table 30 UK Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
Table 31 UK Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
Table 32 UK Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 33 UK Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 34 UK Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
Table 35 France Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
Table 36 France Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
Table 37 France Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 38 France Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 39 France Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
Table 40 Italy Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
Table 41 Italy Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
Table 42 Italy Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million
Table 43 Italy Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 44 Italy Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
Table 45 Spain Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
Table 46 Spain Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
Table 47 Spain Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 48 Spain Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 49 Sapin Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
Table 50 Denmark Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
Table 51 Denmark Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
Table 52 Denmark Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 53 Denmark Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 54 Denmark Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
Table 55 Sweden Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
Table 56 Sweden Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
Table 57 Sweden Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 58 Sweden Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 59 Sweden Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
Table 60 Norway Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
Table 61 Norway Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
Table 62 Norway Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 63 Norway Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 64 Norway Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
Table 65 Asia Pacific Osteoarthritis Therapeutics Market, by country, 2018 - 2030 (USD Million)
Table 66 Asia Pacific Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
Table 67 Asia Pacific Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
Table 68 Asia Pacific Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 69 Asia Pacific Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 70 Asia Pacific Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
Table 71 Japan Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
Table 72 Japan Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
Table 73 Japan Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 74 Japan Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 75 Japan Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
Table 76 China Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
Table 77 China Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
Table 78 China Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 79 China Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 80 China Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
Table 81 India Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
Table 82 India Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
Table 83 India Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 84 India Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 85 India Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
Table 86 Australia Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
Table 87 Australia Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
Table 88 Australia Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 89 Australia Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 90 Australia Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
Table 91 South Korea Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
Table 92 South Korea Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
Table 93 South Korea Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 94 South Korea Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 95 South Korea Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
Table 96 Thailand Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
Table 97 Thailand Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
Table 98 Thailand Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 99 Thailand Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 100 Thailand Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
Table 101 Latin America Osteoarthritis Therapeutics Market, by country, 2018 - 2030 (USD Million)
Table 102 Latin America Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
Table 103 Latin America Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
Table 104 Latin America Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million
Table 105 Latin America Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 106 Latin America Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
Table 107 Brazil Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
Table 108 Brazil Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
Table 109 Brazil Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 110 Brazil Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 111 Brazil Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
Table 112 Mexico Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
Table 113 Mexico Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
Table 114 Mexico Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 115 Mexico Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 116 Mexico Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
Table 117 Argentina Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
Table 118 Argentina Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
Table 119 Argentina Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 120 Argentina Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 121 Argentina Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
Table 122 MEA Osteoarthritis Therapeutics Market, by country, 2018 - 2030 (USD Million)
Table 123 MEA Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
Table 124 MEA Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
Table 125 MEA Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 126 MEA Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 127 MEA Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
Table 128 South Africa Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
Table 129 South Africa Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
Table 130 South Africa Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 131 South Africa Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 132 South Africa Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
Table 133 Saudi Arabia Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
Table 134 Saudi Arabia Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
Table 135 Saudi Arabia Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 136 Saudi Arabia Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 137 Saudi Arabia Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
Table 138 UAE Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
Table 139 UAE Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
Table 140 UAE Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 141 UAE Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 142 UAE Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
Table 143 Kuwait Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
Table 144 Kuwait Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
Table 145 Kuwait Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 146 Kuwait Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 147 Kuwait Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
Table 2 List of key emerging companies/technology disruptors/innovators
Table 3 North America Osteoarthritis Therapeutics Market, by country, 2018 - 2030 (USD Million)
Table 4 North America Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
Table 5 North America Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
Table 6 North America Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 7 North America Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 8 North America Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
Table 9 U.S. Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
Table 10 U.S. Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
Table 11 U.S. Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 12 U.S. Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 13 U.S. Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
Table 14 Canada Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
Table 15 Canada Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
Table 16 Canada Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 17 Canada Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 18 Canada Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
Table 19 Europe Osteoarthritis Therapeutics Market, by country, 2018 - 2030 (USD Million)
Table 20 Europe Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
Table 21 Europe Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
Table 22 Europe Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 23 Europe Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 24 Europe Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
Table 25 Germany Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
Table 26 Germany Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
Table 27 Germany Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 28 Germany Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 29 Germany Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
Table 30 UK Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
Table 31 UK Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
Table 32 UK Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 33 UK Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 34 UK Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
Table 35 France Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
Table 36 France Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
Table 37 France Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 38 France Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 39 France Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
Table 40 Italy Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
Table 41 Italy Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
Table 42 Italy Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million
Table 43 Italy Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 44 Italy Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
Table 45 Spain Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
Table 46 Spain Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
Table 47 Spain Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 48 Spain Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 49 Sapin Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
Table 50 Denmark Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
Table 51 Denmark Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
Table 52 Denmark Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 53 Denmark Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 54 Denmark Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
Table 55 Sweden Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
Table 56 Sweden Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
Table 57 Sweden Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 58 Sweden Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 59 Sweden Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
Table 60 Norway Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
Table 61 Norway Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
Table 62 Norway Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 63 Norway Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 64 Norway Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
Table 65 Asia Pacific Osteoarthritis Therapeutics Market, by country, 2018 - 2030 (USD Million)
Table 66 Asia Pacific Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
Table 67 Asia Pacific Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
Table 68 Asia Pacific Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 69 Asia Pacific Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 70 Asia Pacific Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
Table 71 Japan Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
Table 72 Japan Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
Table 73 Japan Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 74 Japan Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 75 Japan Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
Table 76 China Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
Table 77 China Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
Table 78 China Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 79 China Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 80 China Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
Table 81 India Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
Table 82 India Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
Table 83 India Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 84 India Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 85 India Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
Table 86 Australia Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
Table 87 Australia Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
Table 88 Australia Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 89 Australia Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 90 Australia Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
Table 91 South Korea Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
Table 92 South Korea Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
Table 93 South Korea Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 94 South Korea Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 95 South Korea Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
Table 96 Thailand Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
Table 97 Thailand Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
Table 98 Thailand Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 99 Thailand Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 100 Thailand Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
Table 101 Latin America Osteoarthritis Therapeutics Market, by country, 2018 - 2030 (USD Million)
Table 102 Latin America Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
Table 103 Latin America Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
Table 104 Latin America Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million
Table 105 Latin America Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 106 Latin America Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
Table 107 Brazil Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
Table 108 Brazil Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
Table 109 Brazil Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 110 Brazil Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 111 Brazil Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
Table 112 Mexico Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
Table 113 Mexico Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
Table 114 Mexico Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 115 Mexico Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 116 Mexico Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
Table 117 Argentina Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
Table 118 Argentina Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
Table 119 Argentina Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 120 Argentina Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 121 Argentina Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
Table 122 MEA Osteoarthritis Therapeutics Market, by country, 2018 - 2030 (USD Million)
Table 123 MEA Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
Table 124 MEA Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
Table 125 MEA Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 126 MEA Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 127 MEA Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
Table 128 South Africa Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
Table 129 South Africa Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
Table 130 South Africa Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 131 South Africa Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 132 South Africa Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
Table 133 Saudi Arabia Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
Table 134 Saudi Arabia Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
Table 135 Saudi Arabia Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 136 Saudi Arabia Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 137 Saudi Arabia Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
Table 138 UAE Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
Table 139 UAE Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
Table 140 UAE Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 141 UAE Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 142 UAE Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
Table 143 Kuwait Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
Table 144 Kuwait Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
Table 145 Kuwait Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 146 Kuwait Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
Table 147 Kuwait Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Osteoarthritis Therapeutics Market Segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value chain-based sizing & forecasting
Fig. 7 QFD modelling for market share assessment
Fig. 8 Osteoarthritis Therapeutics Market Snapshot (2023)
Fig. 9 Osteoarthritis Therapeutics Market: Segment snapshot (2023)
Fig. 10 Competitive Insights (2023)
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 Penetration and growth prospect mapping
Fig. 14 Osteoarthritis Therapeutics Market driver impact
Fig. 15 Osteoarthritis Therapeutics Market Restraint Impact
Fig. 16 Clinical chemistry industry challenges
Fig. 17 Porter’s Five Forces Analysis
Fig. 18 SWOT Analysis, By Factor (Political & legal Economic and technological)
Fig. 19 Strategic Alliance analysis
Fig. 20 Recent developments & impact analysis, by key market participants
Fig. 21 Key company market share analysis, 2023
Fig. 22 Company market position analysis
Fig. 23 Definition and scope, by drug type
Fig. 24 Drug type market share analysis, 2023 & 2030
Fig. 25 Segment dashboard
Fig. 26 Global Osteoarthritis Therapeutics Market, by drug type, 2018 - 2030 (USD Million)
Fig. 27 Viscosupplementation Agents market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 28 Nonsteroidal Anti-inflammatory Drugs market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 29 Naproxen market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 30 Aspirin market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 31 Diclofenac market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 32 Ibuprofen market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 33 Celecoxib market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 34 Meloxicam market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 35 Piroxicam market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 36 Ketoprofen market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 37 Other NSAIDs market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 38 Analgesics market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 39 Duloxetine market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 40 Acetaminophen market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 41 Corticosteroids market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 42 Others market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 43 Definition and scope, by Anatomy
Fig. 44 Anatomy market share analysis, 2023 & 2030
Fig. 45 Segment dashboard
Fig. 46 Global Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
Fig. 47 Knee Osteoarthritis market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 48 Hip Osteoarthritis market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 49 Hand Osteoarthritis market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 50 Others market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 51 Definition and scope, by Route of Administration
Fig. 52 Anatomy market share analysis, 2023 & 2030
Fig. 53 Segment dashboard
Fig. 54 Global Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Fig. 55 Parenteral route market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 56 Hyaluronic acid injections market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 57 Corticosteroid Injections market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 58 Platelet-rich Plasma (PRP) Injections market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 59 Placental Tissue Matrix (PTM) Injections market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 60 Acetylsalicylic Acid (ASA) Injections market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 61 Others market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 62 Topical Route market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 63 Oral route market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 64 Definition and Scope, by Sales Channel
Fig. 65 Sales Channel market share analysis, 2023 & 2030
Fig. 66 Segment dashboard
Fig. 67 Global Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
Fig. 68 Prescription Drugs market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 69 Over-the-counter drugs market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 70 Definition and Scope, by End Use
Fig. 71 End Use Market Share Analysis, 2023 & 2030
Fig. 72 Segment dashboard
Fig. 73 Global Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
Fig. 74 Hospital Pharmacies market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 75 Retail Pharmacies market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 76 Others market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 77 North America market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 78 U.S. market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 79 Canada market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 80 Europe market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 81 UK market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 82 Germany market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 83 Spain market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 84 France market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 85 Italy market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 86 Sweden market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 87 Denmark market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 88 Norway market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 89 Asia Pacific market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 90 China market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 91 Japan market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 92 India market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 93 Australia market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 94 South Korea market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 95 Thailand market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 96 Latin America market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 97 Brazil market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 98 Mexico market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 99 Argentina market size, & forecasts and trend analysis, 2018 to 2030 (USD Million))
Fig. 100 Middle East and Africa market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 101 South Africa market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 102 Saudi Arabia market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 103 UAE market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 104 Kuwait market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value chain-based sizing & forecasting
Fig. 7 QFD modelling for market share assessment
Fig. 8 Osteoarthritis Therapeutics Market Snapshot (2023)
Fig. 9 Osteoarthritis Therapeutics Market: Segment snapshot (2023)
Fig. 10 Competitive Insights (2023)
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 Penetration and growth prospect mapping
Fig. 14 Osteoarthritis Therapeutics Market driver impact
Fig. 15 Osteoarthritis Therapeutics Market Restraint Impact
Fig. 16 Clinical chemistry industry challenges
Fig. 17 Porter’s Five Forces Analysis
Fig. 18 SWOT Analysis, By Factor (Political & legal Economic and technological)
Fig. 19 Strategic Alliance analysis
Fig. 20 Recent developments & impact analysis, by key market participants
Fig. 21 Key company market share analysis, 2023
Fig. 22 Company market position analysis
Fig. 23 Definition and scope, by drug type
Fig. 24 Drug type market share analysis, 2023 & 2030
Fig. 25 Segment dashboard
Fig. 26 Global Osteoarthritis Therapeutics Market, by drug type, 2018 - 2030 (USD Million)
Fig. 27 Viscosupplementation Agents market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 28 Nonsteroidal Anti-inflammatory Drugs market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 29 Naproxen market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 30 Aspirin market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 31 Diclofenac market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 32 Ibuprofen market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 33 Celecoxib market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 34 Meloxicam market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 35 Piroxicam market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 36 Ketoprofen market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 37 Other NSAIDs market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 38 Analgesics market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 39 Duloxetine market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 40 Acetaminophen market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 41 Corticosteroids market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 42 Others market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 43 Definition and scope, by Anatomy
Fig. 44 Anatomy market share analysis, 2023 & 2030
Fig. 45 Segment dashboard
Fig. 46 Global Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
Fig. 47 Knee Osteoarthritis market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 48 Hip Osteoarthritis market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 49 Hand Osteoarthritis market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 50 Others market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 51 Definition and scope, by Route of Administration
Fig. 52 Anatomy market share analysis, 2023 & 2030
Fig. 53 Segment dashboard
Fig. 54 Global Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Fig. 55 Parenteral route market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 56 Hyaluronic acid injections market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 57 Corticosteroid Injections market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 58 Platelet-rich Plasma (PRP) Injections market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 59 Placental Tissue Matrix (PTM) Injections market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 60 Acetylsalicylic Acid (ASA) Injections market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 61 Others market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 62 Topical Route market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 63 Oral route market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 64 Definition and Scope, by Sales Channel
Fig. 65 Sales Channel market share analysis, 2023 & 2030
Fig. 66 Segment dashboard
Fig. 67 Global Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
Fig. 68 Prescription Drugs market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 69 Over-the-counter drugs market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 70 Definition and Scope, by End Use
Fig. 71 End Use Market Share Analysis, 2023 & 2030
Fig. 72 Segment dashboard
Fig. 73 Global Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
Fig. 74 Hospital Pharmacies market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 75 Retail Pharmacies market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 76 Others market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 77 North America market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 78 U.S. market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 79 Canada market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 80 Europe market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 81 UK market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 82 Germany market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 83 Spain market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 84 France market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 85 Italy market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 86 Sweden market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 87 Denmark market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 88 Norway market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 89 Asia Pacific market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 90 China market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 91 Japan market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 92 India market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 93 Australia market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 94 South Korea market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 95 Thailand market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 96 Latin America market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 97 Brazil market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 98 Mexico market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 99 Argentina market size, & forecasts and trend analysis, 2018 to 2030 (USD Million))
Fig. 100 Middle East and Africa market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 101 South Africa market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 102 Saudi Arabia market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 103 UAE market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 104 Kuwait market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Companies Mentioned
- Sanofi SA
- GlaxoSmithKline plc
- Pfizer Inc.
- Bayer AG
- Zimmer Biomet
- Novartis AG
- Anika Therapeutics
- Assertio Therapeutics, Inc.
- Bioventus
- Ferring Pharmaceuticals Inc.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 150 |
| Published | March 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 8.59 Billion |
| Forecasted Market Value ( USD | $ 13.57 Billion |
| Compound Annual Growth Rate | 6.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
